Bexxar tositumomab iodine I 131 B cell antibody: CLTR began an expanded access program

By WIR Staff | Oct 5, 1998 | 7:00 AM GMT

Coulter Pharmaceutical Inc. (CLTR), Palo Alto,

Read the full 67 word article

How to gain access

Continue reading with a
two-week free trial.